×
返回 Agenda
Session 3 : How to Leverage Innovative Tools to Accelerate Drug development for Asian Patients
Session Chair(s)
Hyouyoung Rhim, MD, MSc
Vice President
Yuhan Pharm inc., Korea, Republic of
Jing Ping Yeo, PhD, MBA
Vice President, Clinical Operations & Head, Asia Pacific Precision for Medicine
Precision for Medicine, Singapore
Speaker(s)
Meghana Chalasani, MHA
FDA, United States
Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
Session 3 - 2
Sergey Denisov
Seltasquare, Korea, Republic of
Sr. ML Engineer
Session 3 - 3
Henry Wu
AstraZeneca R&D China, China
Sr. Director, Regional Lead-China, HK and Eurasia
Session 3 - 4
Atsushi Ogawa
ICON Japan K.K., Japan
Fengyun (Vicky) Han
Johnson & Johnson Pte. Ltd., Singapore
Senior Director, Head of Regulatory Policy for Asia Pacific
Jing Ping Yeo, PhD, MBA
Precision for Medicine, Singapore
Vice President, Clinical Operations & Head, Asia Pacific Precision for Medicine